NCT04150289View on ClinicalTrials.gov

A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat

CompletedOBSERVATIONAL
Enrollment

248

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

March 30, 2022

Study Completion Date

March 30, 2022

Conditions
Multiple Myeloma
Interventions
DRUG

Farydak

non-interventional study

Trial Locations (7)

17325

Gettysburg Cancer Center, Gettysburg

28078

Southern Oncology Specialists, Huntersville

28204

Oncology Specialists of Charlotte, Charlotte

29572

Coastal Cancer Center, Myrtle Beach

29732

Carolina Blood and Cancer Care Associates, Rock Hill

46260

American Health Network Indiana, Indianapolis

89106

Southern Nevada Cancer Research Foundation and Optum Cancer Care, Las Vegas

All Listed Sponsors
lead

pharmaand GmbH

INDUSTRY

NCT04150289 - A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat | Biotech Hunter | Biotech Hunter